Joshua S. Prince

CIK: 0001998663

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VTGN

Vistagen Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

VTGN
Vistagen Therapeutics, Inc.
Apr 7, 2026
Award(A)
Incentive Stock Option (right to buy)
Direct
18.8K shares-
VTGN
Vistagen Therapeutics, Inc.
Apr 7, 2026
Award(A)
Non-Qualified Stock Option (right to buy)
Direct
56.2K shares-
VTGN
Vistagen Therapeutics, Inc.
Dec 31, 2025
Award(A)
Direct
4.4K shares at avg. $0.56$2K
VTGN
Vistagen Therapeutics, Inc.
Jun 30, 2025
Award(A)
Direct
4.9K shares at avg. $1.70$8K
VTGN
Vistagen Therapeutics, Inc.
Jun 23, 2025
Award(A)
Stock Option (Right to Buy)
Direct
100K shares-
VTGN
Vistagen Therapeutics, Inc.
Dec 31, 2024
Award(A)
Direct
3.3K shares at avg. $2.51$8K

		Type	Shares	Price		Ownership
Apr 7, 2026	VTGN Vistagen Therapeutics, Inc.	Award(A) Incentive Stock Option (right to buy)	18,752	-	-	Direct
Apr 7, 2026	VTGN Vistagen Therapeutics, Inc.	Award(A) Non-Qualified Stock Option (right to buy)	56,248	-	-	Direct
Dec 31, 2025	VTGN Vistagen Therapeutics, Inc.	Award(A)	4,386	$0.56	$2,468	Direct
Jun 30, 2025	VTGN Vistagen Therapeutics, Inc.	Award(A)	4,882	$1.70	$8,299	Direct
Jun 23, 2025	VTGN Vistagen Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	100,000	-	-	Direct
Dec 31, 2024	VTGN Vistagen Therapeutics, Inc.	Award(A)	3,310	$2.51	$8,300	Direct

1-6 of 6 transactions

About Prince Joshua S.

Prince Joshua S. (SEC CIK 0001998663) files insider reports with the SEC as Chief Operating Officer of Vistagen Therapeutics, Inc. (VTGN).

Signal8 holds 5 ownership filings by Prince Joshua S., all Form 4s, filed between Jan 13, 2025 and Apr 9, 2026. Those filings report 6 transactions, from Dec 31, 2024 to Apr 7, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Prince Joshua S.'s filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Prince Joshua S.

Apr 7, 2026: Grants or awards of VTGN derivative securities (2 lines, Form 4, code A).
Dec 31, 2025: Grant or award of VTGN shares (Form 4, code A).
Jun 30, 2025: Grant or award of VTGN shares (Form 4, code A).
Jun 23, 2025: Grant or award of VTGN derivative securities (Form 4, code A).
Dec 31, 2024: Grant or award of VTGN shares (Form 4, code A).

Other insiders filing for Vistagen Therapeutics, Inc. (VTGN)

Williamson Douglas J, Officer
Adler Reid G., Chief Legal Officer
Tressler Nick B., Chief Financial Officer
Singh Shawn, President and CEO
Angelov Angel S, Chief Medical Officer
Cote Elissa S., Chief Corp Development Officer

How to read Form 4 transaction codes